Alkermes
artistry determined selected as recommended phase dose for artistry efficacy expansion stage selection of based on totality of data including safety and efficacy during dose phase acceptable safety and tolerability profile consistent with the anticipated pharmacological effect and that observed with intravenous dose dependent increases in cell and cell activation and minimal increase in clinical benefit stable disease observed additional artistry data to be presented at future medical meeting phase efficacy expansion initiated based on totality of dose data regulatory cell natural killer pharmacodynamic | Alkermes
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
77 of 144
Related slides by other companies
DICE Therapeutics
Results
March 2023
key from phase efficacy results dice | DICE Therapeutics
Immatics
Investor Presentation
November 2023
phase clinical trial to evaluate targeting | Immatics
Oculis
Investor Presentation
July 2023
towards the assessment of the efficacy of in patients phase acuity trial in acute optic neuritis | Oculis
Dare Bioscience
Investor Presentation
February 2023
cream phase ongoing phase clinical study aims to evaluate cream placebo over weeks of dosing following both a non drug and placebo run in period compares cream placebo used in patients home setting primary patient reported outcome pro instruments to measure improvement in localized genital sensations of arousal and reduction in related distress several exploratory efficacy will be measured and could become additional measurements of efficacy in a future phase program topline data of phase respond study targeted for | Dare Bioscience
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io